Product Reports Resources Pricing Login Book a demo

Circadia

Biotech & Life Sciences · London, United Kingdom · Founded 2016

Contactless patient monitoring system for predictive healthcare MoreLess

Circadia Health develops AI-powered contactless patient monitoring systems designed for early detection of health complications, primarily serving the senior care sector. Founded in 2016 by CEO Fares Siddiqui and CTO Michal Maslik, the company aims to shift healthcare from a reactive to a proactive model. Siddiqui, who has a background in mechanical engineering and product design, was driven to medtech by a desire to create life-saving inventions. He met Maslik, an electrical engineering student, at Imperial College London, forming the foundation of the company.

The company's core technology is a bedside device that uses radar to monitor vital signs like respiratory rate and heart rate, along with patient motion and bed exits, from up to eight feet away without physical contact. This data is analyzed by proprietary AI algorithms to identify trends and predict potential medical events such as congestive heart failure, pneumonia, and sepsis hours or days in advance. The system received its first FDA 510(k) clearance in June 2020 for its C100 model, which focused on contactless respiratory rate monitoring. In November 2024, the C200 system received expanded FDA clearance to include heart rate, motion, and bed exit monitoring.

Circadia operates on a subscription-based business model, providing its technology and services to skilled nursing facilities and other long-term care providers. A team of virtual nurses reviews the collected data and provides 24/7 predictive risk alerts to clinicians, integrating with electronic health records to offer detailed trend analysis. This service helps facilities reduce preventable hospitalizations, lower care costs, and improve patient outcomes. The company's platform is also designed to be reimbursable through Medicare remote patient monitoring codes.

Keywords: contactless patient monitoring, predictive analytics, remote patient monitoring, senior care technology, FDA-cleared medical device, respiratory monitoring, heart rate monitoring, skilled nursing facilities, early detection healthcare, AI in healthcare, vital signs monitoring, fall prevention, chronic care management, health technology, radar sensing, clinical decision support, virtual nursing

Talent graph

Circadia's talent

Book a demo to see the people
Team profiled 10 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators 3 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Investors

7 investors on Circadia's cap table

Sourced from Dealroom's funding and investor records. Investor profile links are shown where available.

Seed 2 investors entered at this stage
Village Global
Centregold Capital
Series A 5 investors entered at this stage
SOSV
Hax
Kickstarter
Indiegogo
Particular Ventures

Global footprint

Where Circadia has talent and traffic

Workforce by country
6 countries with
team presence
🇺🇸 United States50%
🇵🇰 Pakistan23%
🇬🇧 United Kingdom21.6%
🇩🇪 Germany2.7%
🇵🇭 Philippines1.4%
Top 5 of 6 shown

Market sentiment

What the market is saying about Circadia

An AI-synthesized read of the highest-engagement posts about Circadia on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Circadia on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.